Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

77.29 +2.24 (+2.98%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	542,953
Open	75.10
Bid (Size)	73.78 (400)
Ask (Size)	79.00 (100)
Prev. Close	75.05
Today's Range	74.93 - 78.98
52wk Range	49.00 - 117.33
Shares Outstanding	115,926,629
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Corcept Therapeutics Inc (NASDAQ:CORT) Presents a Strong Growth and Technical Breakout Case ↗

Today 6:01 EST

Corcept Therapeutics (CORT) combines strong fundamentals, including robust revenue growth and a healthy balance sheet, with a positive technical breakout setup.

Via Chartmill

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Via StockStory

Performance

YTD	+54.7%	+54.7%
1 Month	+4.9%	+4.9%
3 Month	+9.9%	+9.9%
6 Month	-1.8%	-1.8%
1 Year	+38.2%	+38.2%

More News

CORCEPT THERAPEUTICS INC (NASDAQ:CORT): A Case Study in Affordable Growth Investing ↗

November 18, 2025

Via Chartmill

1 Growth Stock with Explosive Upside and 2 We Brush Off

November 17, 2025

Via StockStory

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Corcept (NASDAQ:CORT)

November 12, 2025

Via StockStory

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know

November 11, 2025

Via StockStory

The 5 Most Interesting Analyst Questions From Corcept’s Q3 Earnings Call

November 11, 2025

Via StockStory

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

Via MarketMinute

Peering Into Corcept Therapeutics Inc's Recent Short Interest ↗

November 06, 2025

Via Benzinga

CORT Q3 Deep Dive: Pharmacy Transition and Pipeline Expansion Drive Mixed Outlook

November 05, 2025

Via StockStory

Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q3 Earnings

November 04, 2025

Via StockStory

Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update

November 04, 2025

From Corcept Therapeutics Incorporated

Via Business Wire

Corcept Earnings: What To Look For From CORT

November 02, 2025

Via StockStory

3 Healthcare Stocks We Steer Clear Of

October 31, 2025

Via StockStory

3 Cash-Producing Stocks with Open Questions

October 29, 2025

Via StockStory

Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call

October 28, 2025

From Corcept Therapeutics Incorporated

Via Business Wire

Beyond The Numbers: 6 Analysts Discuss Corcept Therapeutics Stock ↗

October 20, 2025

Via Benzinga

Corcept Therapeutics Stock Slips Premarket Despite Strong Cancer Trial Data Showing 40% Drop In Disease Progression Risk ↗

October 20, 2025

Via Stocktwits

Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment

October 19, 2025

From Corcept Therapeutics Incorporated

Via Business Wire

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm

October 16, 2025

Via StockStory

Corcept (CORT) Shares Skyrocket, What You Need To Know

October 15, 2025

Via StockStory

Corcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer

October 14, 2025

From Corcept Therapeutics Incorporated

Via Business Wire

3 High-Flying Stocks We Approach with Caution

October 13, 2025

Via StockStory

3 Profitable Stocks That Concern Us

October 10, 2025

Via StockStory

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?

Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.

What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?

Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?

The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market

What is the current price of Corcept Therapeutics Incorporated - Common Stock?

The current price of Corcept Therapeutics Incorporated - Common Stock is 77.29

When was Corcept Therapeutics Incorporated - Common Stock last traded?

The last trade of Corcept Therapeutics Incorporated - Common Stock was at 11/21/25 04:00 PM ET

What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?

The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 8.96B

How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?

Corcept Therapeutics Incorporated - Common Stock has 9B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.